NeoLight, LLC

NeoLight, LLC manufactures specialized medical devices for neonatal intensive care, including brain monitoring, retinal imaging, phototherapy, and developmental support systems. The company's product portfolio addresses critical clinical needs in NICU environments: the nëo™ CFM with aEEG provides cerebral function monitoring to support decision-making in neurological assessment; the ICON™ retinal imaging system with patented Direct Illumination™ technology enables screening for retinopathy of prematurity and other ocular conditions; the Skylife™ Neonatal Phototherapy System delivers spectral power-optimized treatment for neonatal jaundice; and the P.A.L. (Pacifier-Activated Latch) device encourages non-nutritive sucking to promote oral feeding development in preterm and critically ill infants. NeoLight's devices are designed for use in tertiary and secondary neonatal care settings, emphasizing evidence-based clinical outcomes and user-centered design. The company positions itself as a neonatal innovation leader integrating advanced monitoring, diagnostic imaging, and therapeutic technologies to improve developmental outcomes and reduce NICU length of stay.